Teriparatide Injection

Teriparatide Injection

5110.0 INR

Product Details:

  • Indication Osteoporosis, high risk of fracture
  • Dosage Form Injection
  • Salt Composition Teriparatide (750mcg)
  • Origin of Medicine Allopathic
  • Pacakaging (Quantity Per Box) 1 pre-filled pen per box
  • Drug Type Hormonal preparation
  • Ingredients Sevoflurane
  • Click to view more
X

Teriparatide Injection Price And Quantity

  • 5110.0 INR
  • 40

Teriparatide Injection Product Specifications

  • Adults
  • Anti-Bacterial
  • As prescribed by physician
  • Subcutaneous use only. Administer once daily as directed.
  • Hormonal preparation
  • Sevoflurane
  • Other
  • 1 pre-filled pen per box
  • Adults with osteoporosis at high risk for fracture
  • Injection
  • Osteoporosis, high risk of fracture
  • 3 ml
  • Teriparatide (750mcg)
  • Allopathic
  • Store in a refrigerator (2C 8C). Do not freeze.

Teriparatide Injection Trade Information

  • Cash Advance (CA), Cash in Advance (CID), Telegraphic Transfer (T/T)
  • 1000 Per Week
  • 4 Days
  • No
  • If order is confirmed we will reimburse the sample cost
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • All India

Product Description

1. Technical Specifications

Form

Injection

Dose

750 mcg/3 ml

PackagingSize

1x1 Cartridge

PackagingType

Box

Brand

Terifrac

ProductType Finished Product
Usage Clinical, Hospital, Personal


2. Product Description

Terifrac Injection contains Teriparatide, a recombinant human parathyroid hormone fragment (rPTH 134) that stimulates new bone formation. It is indicated for treatment of osteoporosis in men and postmenopausal women at high fracture risk. Therapy is typically limited to a maximum of 24 months lifetime exposure due to potential long-term safety concerns.

3. Therapeutic Uses

  • Management of osteoporosis in postmenopausal women at high fracture risk

  • Osteoporosis in men with elevated fracture risk

  • Not recommended for patients with high osteosarcoma risk, children, or young adults with open epiphyses


4. Safety Profile & Side Effects

Common adverse effects:

  • Nausea, headache, muscle cramps

  • Back pain, injection-site pain, bruising, increased urinary frequency, dry mouth

Serious or rare risks:

  • Osteosarcoma observed in animal studies; relevance to humans is uncleartherapy limited to 24 months lifetime exposure

  • Transient orthostatic hypotension (lightheadedness), transient hypercalcemia, potential impact on kidney stones or elevated urinary calcium levels


5. Precautions

  • Contraindicated in patients with bone cancer, Pagets disease, unexplained elevated alkaline phosphatase, prior radiation therapy involving skeleton, or high risk of osteosarcoma

  • Maximum duration: 24 months over lifetime

  • Caution in patients with renal impairment or history of urolithiasis due to altered calcium excretion

  • May cause dizziness after dosingadvise patients to sit or lie down until symptoms pass

  • Not recommended during pregnancy or breastfeeding unless essential

  • Avoid in children or young adults with open epiphyses

  • Use judiciously in patients with pre-existing hypercalcemia or kidney stones




How Teriparatide Injection Works

Teriparatide is a recombinant form of parathyroid hormone, working to stimulate new bone formation in adults with osteoporosis at high risk for fractures. By boosting bone build-up, it strengthens the skeleton and reduces the likelihood of broken bones. This makes it a valuable treatment option under physician supervision.


Administration and Proper Usage

The injection is administered subcutaneouslyusually in the thigh or abdomenonce daily as directed by a physician. Only adults should use this product, and it should not be shared or reused. Follow aseptic handling and strictly adhere to your healthcare providers dosage guidelines for best results.


Storage and Shelf Life Recommendations

To ensure stability and potency, store the Teriparatide Injection in its original packaging in a refrigerator at 2C8C. Do not freeze the pen. Make sure to observe the expiration date indicated on the label, which is typically 24 months from production.

FAQs of Teriparatide Injection:


Q: What medical condition is Teriparatide Injection recommended for?

A: Teriparatide Injection is recommended for adults with osteoporosis who are at a high risk for fracture. It stimulates bone formation, helping to increase bone strength and decrease fracture risk.

Q: How should Teriparatide Injection be administered?

A: This medication is administered subcutaneously, typically once daily, as prescribed by your physician. It is injected under the skin, commonly in the thigh or abdomen.

Q: Where should I store my Teriparatide Injection?

A: Store the pre-filled pen in a refrigerator at 2C8C. Do not freeze. Keep the pen in its original packaging to protect it from light, and always check the expiry date before use.

Q: How long can I use the Teriparatide Injection after opening?

A: You should use the Teriparatide Injection within the expiry date stated on the label, typically 24 months if stored correctly. Discard any unused portion if it becomes discolored, cloudy, or past its expiry date.

Q: Can I reuse or share my Teriparatide Injection pen?

A: No, never reuse or share the injection pen. This can lead to contamination and risk of infection. Always use a new needle for each injection as instructed by your healthcare provider.

Q: What are the primary benefits of using Teriparatide Injection?

A: The main benefit is increased bone formation, which results in enhanced bone density and a lower risk of fractures in those diagnosed with osteoporosis.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Pharmaceutical Injection' category



Back to top